Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Chugai

- PMLiVE

Empowering expertise in an age of complexity

Leadership doesn’t always mean having the answers - it means creating the conditions for others to succeed

- PMLiVE

AstraZeneca’s Alexion agrees on $775m settlement with Chugai for Ultomiris

The two companies will withdraw patent infringement proceedings filed with the US and Japan

- PMLiVE

Medimmune-born Viela files $150m IPO, eyes first product launch

Funds will help to push a number of pipeline candidates

- PMLiVE

Chugai gains FDA breakthrough status for rare CNS treatment

Adds to company's BTD roll-call

- PMLiVE

First blood to Roche in Hemlibra patent fight with Shire

The new haemophilia drug does not infringe Baxalta’s patent, rules Tokyo court

Roche Basel Switzerland

Roche’s haemophilia A drug hits targets in registration trial

Emicizumab from Japanese affiliate Chugai cleared a phase III trial

Product updates from Japan

New approvals and filings include drugs from Takeda, Otsuka, Chugai and Astellas

- PMLiVE

Chugai appoints Ruth Currie as MD of its UK business

She replaces John Halls, who has been promoted

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links